Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Apr 21, 2010; 16(15): 1896-1900
Published online Apr 21, 2010. doi: 10.3748/wjg.v16.i15.1896
Table 1 Clinical characteristics of patients taking LDA enrolled in the present study
Patients with ulcer (n = 119)Patients without ulcer (n = 334)P-value
Gender (male/female)87/32211/123NS
Age (yr), median (range)73.0 (47-92)72.0 (45-95)NS
Male (n = 298)70.0 (47-92)71.0 (43-93)NS
Female (n = 155)77.0 (54-92)73.0 (47-95)0.0338
Underlying disease (male/female)
Ischemic heart disease77 (61/16)205 (131/74)NS
Cerebral infarction22 (10/12)70 (39/31)NS
Atrial fibrillation16 (13/3)43 (28/15)NS
Others4 (3/1)16 (13/3)NS
Symptoms (male/female)
Melena, hematemesis46 (29/17)1 (0/1)< 0.0001
GI symptoms31 (21/10)107 (72/35)NS1
Anemia17 (14/3)40 (21/19)0.0156
Body weight loss1 (1/0)7 (5/2)0.0087
Appetite loss1 (1/0)8 (2/6)0.0028
None (medical check)18 (15/3)146 (96/50)0.0025
Others5 (2/0)25 (15/10)> 0.9999
Helicobacter pylori62.3% (43/69)-
Male66.7% (30/45)-
Female54.2% (13/24)-